Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05389254
Status:
UNKNOWN
Last Update Posted:
2022-05-25
First Post:
2022-05-17
Brief Title:
Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome
Sponsor:
Ningbo No 1 Hospital
Organization:
Ningbo No 1 Hospital
Study Overview
Official Title:
Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetes Mellitus Patients With Acute Coronary Syndrome
Status:
UNKNOWN
Status Verified Date:
2022-05
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to use real-time continuous glucose monitoring real-time CGM system to get a 14-days blood glucose profile of the hospitalized type 2 diabetes mellitus T2DM patients with acute coronary syndrome ACS and to understand whether time in range TIR is associated with in-hospital outcomes of these patients This study plans to recruit 100 patients They will be randomly divided into 2 groups real-time CGM group and capillary blood glucose monitoring group All enrolled participants will receive standardized blood glucose management according to the Expert consensus on blood glucose management of inpatients in China The duration of the study will be 3 months The primary endpoint is the average hospital stay and cardiac care unit CCU occupancy rate in T2DM patients with ACS The secondary endpoint is a composite endpoint of nonfatal myocardial infarction acute heart failure heart failure rehospitalization coronary revascularization cardiovascular death all-cause death
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None